Please assess the completion status of the following clinical trial:

Trial Title: Preventing Post-Stroke Depression

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Stroke within the last 120 days~Exclusion Criteria:~* DSM (Diagnostic and Statistical Manual) IV criteria for major or minor depressive disorder~* Heart, respiratory, kidney, or liver failure; severely disabling musculoskeletal disorder; or cancer~* Diagnosis of neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, Multiple System Atrophy, or Huntington's disease~* Pre-existing dementia or aphasia with severe language comprehension deficits~* Alcohol or substance abuse or dependence within the last 12 months~* Recurrent unipolar or bipolar disorder prior to the stroke

- Gender: ALL
- Minimum Age: 31 Years
- Maximum Age: 89 Years
- Healthy Volunteers: f

Study Arms:
- 1 Problem Solving Therapy (Type: EXPERIMENTAL): Participants will receive problem solving therapy.
- 2. Escitalopram (Type: EXPERIMENTAL): Participants will receive escitalopram.
- 3 Placebo (Type: PLACEBO_COMPARATOR): Participants will receive placebo.

Based on this trial design, predict the completion outcome and termination type (if applicable).